[Association between ESR1 gene polymorphisms and haplotypes with schizophrenia]
Li-wen Wang1, Shu-ping He, Jing-liang Zhang
1Department of Cell Biology and Medical Genetics, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
Summary
Genetic variations in the estrogen receptor 1 (ESR1) gene, specifically the rs3798759 polymorphism and certain haplotypes, may increase schizophrenia risk, particularly in females.
Area of Science:
- Genetics
- Psychiatry
- Molecular Biology
Context:
- Schizophrenia is a complex psychiatric disorder with a significant genetic component.
- The estrogen receptor 1 (ESR1) gene plays a role in neurodevelopment and function.
- Investigating genetic variations like single nucleotide polymorphisms (SNPs) can elucidate schizophrenia's etiology.
Purpose:
- To examine the association between specific ESR1 gene SNPs and haplotypes and schizophrenia.
- To identify potential genetic risk factors for schizophrenia.
Summary:
- This study analyzed three ESR1 SNPs (rs2234693, rs9340799, rs3798759) and haplotypes in 333 schizophrenia patients and 315 healthy controls.
- Significant differences were found in the rs3798759 G allele and GG genotype frequencies between groups, especially in female patients.
- Haplotypes C-A-G and C-G-G were more prevalent in the schizophrenia group.
Impact:
- The rs3798759 polymorphism may represent a risk factor for schizophrenia in females.
- Specific ESR1 haplotypes (C-A-G, C-G-G) are potentially associated with an increased risk of schizophrenia.
- Findings contribute to understanding the genetic underpinnings of schizophrenia and may inform future research and potential therapeutic targets.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:29Psychological and Sociocultural Causes of Schizophrenia
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
01:29Biological Causes of Schizophrenia
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...